| Accession |
PRJCA012406 |
| Title |
M-AS-273-01 |
| Relevance |
Medical |
| Data types |
PK data
|
| Organisms |
Homo sapiens
|
| Description |
This was a Phase I single centre open label study to investigate the pharmacokinetics PK safety and tolerability of single and multiple twice daily BID doses of inhaled aclidinium bromide in healthy Chinese male and female participantsThe primary objective is To investigate the PK of aclidinium bromide and its metabolites after single and multiple doses of aclidinium bromide in healthy Chinese participants |
| Sample scope |
Multiisolate |
| Release date |
2022-10-12 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| Astra Zeneca AB
|
|
2021LP00700
|
|
|
|
| Submitter |
Li
Wei
Min (Weimin003@163.com)
|
| Organization |
West China Hospital of Sichuan University |
| Submission date |
2022-10-10 |
